Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 2INDUSTRY 2NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 6Head and Neck Neoplasms 2Waldenstrom Macroglobulinemia 1Urinary Bladder Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Invasive Breast Cancer 1Inflammatory Breast Neoplasms 1Immunoblastic Lymphadenopathy 1Her2 Positive Metastatic Breast Cancer 1Burkitt Lymphoma 1Breast Neoplasms, Male 1

Interventions

Cyclophosphamide 5Epirubicin 4Docetaxel 4pegfilgrastim 2Trastuzumab 2Radiotherapy 2Filgrastim 2Doxorubicin 2Bevacizumab 2Taxes 1Surgical Procedures, Operative 1Paclitaxel 1Neoadjuvant Therapy 1Microarray Analysis 1Lapatinib 1Immunohistochemistry 1Granulocyte Colony-Stimulating Factor 1Fluorouracil 1Capecitabine 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Inflammatory Breast Neoplasms × Lapatinib × Clear all
NCT00450892 2016-07-07

Phase I/II Study of Neoadjuvant Lapatinib in Breast Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 1/2 Completed
129 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡